Hannah Joseph Hospital IPO Commences: Key Details and Subscription Status
The initial public offering (IPO) of Hannah Joseph Hospital Limited opened for subscription on Thursday, January 22, and will conclude on Tuesday, January 27. This marks a significant milestone for the Madurai-based healthcare provider as it seeks to raise capital for expansion and service enhancement.
IPO Pricing and Structure
The Hannah Joseph Hospital IPO price band has been set at ₹67 to ₹70 per equity share, with each share having a face value of ₹10. The total issue size is valued at ₹42 crore, consisting entirely of a fresh issue of 60 lakh shares. Investors can participate by placing bids for a minimum of 2,000 equity shares, with subsequent bids required to be in multiples of 2,000 shares.
For retail investors, the minimum application size translates to 4,000 shares, amounting to an investment of approximately ₹2.8 lakh at the upper end of the price band. High-net-worth individuals (HNIs) are required to invest a minimum of ₹4.2 lakh.
About Hannah Joseph Hospital Limited
Established in 2011, Hannah Joseph Hospital Limited is a prominent provider of healthcare services, delivering outstanding medical care across multiple specialties. The facility is a multi-specialty healthcare center located in Madurai, situated on a 2-acre property equipped with centralized air conditioning and water heating systems. The hospital features a total of 150 beds and specializes in key areas such as:
- Neurology
- Cardiology
- Psychiatry
- Trauma care
The company emphasizes its commitment to recognizing global trends, understanding customer culture, and meeting the requirements of medical professionals, all while fulfilling the need for accessible and quality healthcare services.
Financial Performance and Peer Comparison
Hannah Joseph Hospital has demonstrated consistent financial growth over the past several years. For the six months ending in September 2025, the company achieved a profit after tax of ₹5.12 crore on a total income of ₹42.75 crore. In the fiscal year 2025, the profit was recorded at ₹7.21 crore, with EBITDA margins remaining strong at over 26%.
According to the red herring prospectus, the company's listed peers include:
- Asarfi Hospital Ltd with a price-to-earnings (P/E) ratio of 32.26 times
- Maitreya Medicare Ltd with a P/E ratio of 74.29 times
IPO Subscription Status
As of the first day of bidding, the Hannah Joseph Hospital IPO subscription status stood at 17%, according to data from chittorgarh.com. The breakdown of subscription categories reveals:
- Retail portion: Subscribed 5%
- Non-institutional investors (NII) portion: Booked 67%
- Qualified institutional buyers (QIB) portion: Yet to be booked
The company received bids for 6,70,000 shares against the 39,94,000 shares on offer on the first bidding day, as recorded at 15:04 IST.
Utilization of Proceeds and Grey Market Premium
The proceeds from the IPO will be utilized to enhance the company's healthcare services, with a significant portion allocated for the establishment of a radiation oncology center. This strategic investment aims to expand the hospital's specialty offerings and improve patient care capabilities.
The Hannah Joseph Hospital IPO grey market premium (GMP) was reported at ₹0, indicating that shares were trading at their issue price of ₹70 with no premium or discount in the grey market, according to investorgain.com. The grey market premium typically reflects investor sentiment and willingness to pay above the issue price.
Key Advisors and Market Makers
Capital Square Advisors Pvt. Ltd. serves as the lead manager for this offering, while Bigshare Services Pvt. Ltd. acts as the issue's registrar. The Market Maker for the company is CapitalSquare Financial Services Private Limited, ensuring liquidity and smooth trading post-listing.
Disclaimer: The views and recommendations above are those of individual analysts, experts, and broking companies, not of Mint. Investors are advised to consult with certified experts before making any investment decisions.
